[이데일리 유진희 기자]Global pharmaceutical and bio industry issues of a week (August 15-August 21) were collected. This week, research results related to disease prevention and alleviation drew attention.
|
Healthday News reported that aspirin is helpful in the prevention of ovarian cancer. The research team, led by Professor Lauren Huritz of the US National Cancer Institute (NC), analyzed the data of 17 related research papers that have been published so far. . Of the 17 research papers, 9 were from the ovarian cancer cohort (same cohort: 2600 patients), and 8 were from the experimental-control group (5726 patients).
Overall, the researchers found that women who consumed aspirin frequently had a 13% lower risk of ovarian cancer. Aspirin was more effective in women with more risk factors for ovarian cancer, such as obesity, a family history of ovarian and breast cancer, no childbirth, and taking oral contraceptives.
In women with two or more risk factors for ovarian cancer, aspirin reduced the risk of ovarian cancer by 81%. However, aspirin did not reduce the risk of ovarian cancer in women with endometriosis, a risk factor for ovarian cancer.
The results of this study were published in the latest issue of the Journal of Clinical Oncology, a journal of the American Society of Clinical Oncology.
|
Medical news portal News Medical Life Sciences reported that vitamin D supplementation was effective in relieving depression. This is the result of a comprehensive analysis of data from 41 clinical trials related to vitamin D-depression (set as a randomized control group) published in the world so far by a research team led by Professor Tuomas Mikola at the Institute of Clinical Medicine at Eastern University of Finland.
According to the research team, in all clinical trials, the group taking the vitamin D supplement had less depression than the control group not taking it. The doses of vitamin D supplements taken were significantly different, but those taking 50-100 μg (micrograms) were the most common.
Vitamin D is known to regulate the functions of the central nervous system. Disturbances in the central nervous system are associated with depression. However, the research team said that the results of this trial have low certainty of evidence due to the risk of population heterogeneity and bias among participants.
The results of this study were published in the latest issue of Critical Reviews in Food Science and Nutrition, an American journal of food and nutrition.
